Navigation Links
Galien Foundation Appoints Kimberly Ha of Infinata’s BioPharm Insight to US Advisory Board
Date:3/19/2013

Norwood, MA (PRWEB) March 19, 2013

Infinata’s BioPharm Insight™ is pleased to announce that the Galien Foundation has appointed Kimberly Ha, Global Editor of BioPharm Insight, to their US Advisory Board. The Galien Foundation recognizes excellence in scientific innovation to improve human health and supports the Prix Galien Award Program, often referred to as the Nobel Prize for biopharmaceutical industry research achievement.

“Kimberly Ha joins a group of renowned industry leaders who have joined together to advance the effort to encourage biopharma scientists to pursue breakthrough research that can change the face of health around the globe,” said Bruno Cohen, Chairman, Galien Foundation. “Kimberly’s dedication to healthcare journalism is making people within our industry aware of the immense effort invested in finding solutions to illnesses that limit life’s great potential and her words inspire scientists to face the obstacles inherent in innovation.”

Ms. Ha began her career as a financial journalist in Hong Kong specializing in healthcare mergers and acquisitions, and previously was the sector specialist at Mergermarket, a division of the Financial Times Group. In 2011, based on her extensive coverage of Alzheimer's disease, she was nominated by the Alzheimer's Association and selected as a National Press Foundation Fellow. She is also a recipient of the 2012 National Press Foundation and UN Foundation Global Vaccines Press Fellowship.

Kimberly Ha commented: “It’s a tremendous honor to serve on the Galien Foundation Advisory Board. I look forward to working with my colleagues to advance the Foundation’s mission, offer support to the Prix Galien Committee and highlight important, life-changing advances in medical innovation.”

About the Galien Foundation and the Prix Galien Awards
The mission of the Galien Foundation is to serve as a vehicle for the open exchange of ideas that drive science and new innovations. The Prix Galien Award is considered the industry’s highest accolade, equivalent to the Nobel Prize. Prix Galien was first established in 1970 by French pharmacist Roland Mehl and was inaugurated in the United States in September 2007. For more information about the Prix Galien USA award and committee, visit: http://www.galienfoundation.org.

About BioPharm Insight
BioPharm Insight is the definitive guide to the global biopharma community. BioPharm Insight provides subscribers with an information edge by combining the most comprehensive real-time database of companies, drugs, contacts, M&A and licensing deals, forecasts and clinical trial data with proprietary forward-looking intelligence uncovered by an independent team of investigative journalists months or even years before it breaks in mainstream media. To learn more, visit http://www.biopharminsight.com. Follow BioPharm Insight on LinkedIn and Twitter.

About Infinata, Inc.
Infinata provides personalized technology solutions to turn information into insight. Services include a comprehensive BioPharm Solutions Suite, unique Wealth Prospecting tools and innovative Custom Data Services. Infinata is a part of Mergermarket, a Financial Times Group company and a division of Pearson plc. To learn more, visit http://www.infinata.com.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10535659.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Galien Foundation Announces 2012 Awards Program For Best Biopharmaceutical Products and Best Medical Technology
2. Washington State University to Present on Tin Nanoneedles: A Technology for Lithium-ion Batteries, at Knowledge Foundation’s Next Generation Batteries 2013 Conference
3. The Hartwell Foundation Provides Grant to University of Michigan Researchers
4. Mixed Roots Foundation to Announce New Honorary Board at Anniversary Celebration Benefit Event on May 18 in Sausalito, CA
5. Foundation for the NIH Announces Lurie Prize Recognizing Outstanding Achievement by a Young Biomedical Scientist
6. The Drugs for Neglected Diseases initiative (DNDi) takes the BBVA Foundation Frontiers of Knowledge Award in the Development Cooperation category
7. Brain Research Foundation 2013 Scientific Innovations Awards To Dr. Jean Hebert and Dr. Brian Litt
8. GUARDaHEART Foundation Hosts Love Your Heart Day Event in Celebration of Heart Disease Awareness Month
9. The Elsevier Foundation, TWAS, and OWSD Honor Early Career Women Scientists in Developing Countries at the Annual AAAS Meeting
10. USANA True Health Foundation Sponsors 777 Project - One Man To Run 7 Marathons In 7 Days On 7 Continents
11. TNI BioTech Acquires Exclusive License To The Portfilio Of Patents Of Dr Ian S. Zagon, Dr. Patricia J. McLauglin And Dr. Jill Smith From The Penn State Research Foundation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. Hays ... DNA as a Field Application Specialist. , “I am thrilled that Dr. Young ... DNA. “In further expanding our capacity as a scientific integrator, Hays brings a wealth ...
Breaking Biology Technology:
(Date:4/15/2016)... April 15, 2016  A new partnership announced ... accurate underwriting decisions in a fraction of the ... priced and high-value life insurance policies to consumers ... With Force Diagnostics, rapid testing (A1C, Cotinine ... readings (blood pressure, weight, pulse, BMI, and activity ...
(Date:4/13/2016)... 13, 2016  IMPOWER physicians supporting Medicaid patients in ... new clinical standard in telehealth thanks to a new ... higi platform, IMPOWER patients can routinely track key health ... mass index, and, when they opt in, share them ... to a local retail location at no cost. By ...
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
Breaking Biology News(10 mins):